Barriers to Accessing Effective Treatment and Support for Menopausal Symptoms: A Qualitative Study Capturing the Behaviours, Beliefs and Experiences of Key Stakeholders
Barriers to Accessing Effective Treatment and Support for Menopausal Symptoms: A Qualitative Study Capturing the Behaviours, Beliefs and Experiences of Key Stakeholders
Lack of knowledge about the menopause and the risks and benefits of HRT by women and GPs were the main barriers identified that are preventing women from accessing adequate support for the menopause.
Share
Fezolinetant: a New Nonhormonal Treatment for Vasomotor Symptoms
Source : https://pubmed.ncbi.nlm.nih.gov/37974591/
To review the safety, efficacy, and tolerability of fezolinetant for the treatment of vasomotor symptoms associated with menopause. A literature search was conducted through PubMed.
With the approval of fezolinetant, providers and patients have additional nonhormonal treatment options for vasomotor symptoms associated with menopause.
Share
Systematic Review and Network Meta-Analysis Comparing the Efficacy of Fezolinetant With Hormone and Nonhormone Therapies for Treatment of Vasomotor Symptoms Due to Menopause
The neurokinin 3 receptor antagonist fezolinetant 45 mg/d significantly reduced frequency...
Study data suggest that fezolinetant represents the most effective non-HT option for women who have contraindications for HT or wish not to use HT for the treatment of moderate to severe VMS due to menopause.
Share
"I Can't Be Dealing With This Brain Fog": a Workplace Focus Group Study Investigating Factors Underpinning the Menopausal Experience for NHS Staff
Source : https://pubmed.ncbi.nlm.nih.gov/38029510/
Employers have a key role in supporting their staff experiencing menopausal symptoms, and such support has the potential to reduce sickness absence and boost retention.
Menopause symptom experience in the workplace was multifaceted and varied, depending on factors such as medical history, expectations, social support and effectiveness of management strategies.
Share
Concurrent Uterine Surgery and Uptake of Hormone Therapy in Patients Undergoing Bilateral Salpingo-Oophorectomy for Risk-Reducing or Therapeutic Indications
Source : https://pubmed.ncbi.nlm.nih.gov/37988946/
Rates of hysterectomy declined over the study period and slightly more than one-third of eligible patients utilized post-operative HT. Further research on concurrent uterine surgery is needed to establish standardized...
Utilization of concurrent uterine surgery at the time of risk-reducing or therapeutic bilateral salpingo-oophorectomy varies.
Share